Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.


The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page


My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1945 1
1946 1
1974 1
1977 1
1978 1
1979 1
1980 2
1981 1
1982 5
1983 3
1984 5
1985 12
1986 13
1987 10
1988 11
1989 15
1990 8
1991 2
1992 8
1993 5
1994 5
1995 6
1996 3
1997 16
1998 14
1999 11
2000 3
2001 9
2002 7
2003 10
2004 9
2005 8
2006 12
2007 13
2008 3
2009 7
2010 9
2011 18
2012 21
2013 7
2014 7
2015 8
2016 9
2017 5
2018 7
2019 4
2020 4
2021 4
2022 5
2024 4

Text availability

Article attribute

Article type

Publication date

Search Results

336 results

Results by year

Filters applied: . Clear all
Page 1
Galectins and Ovarian Cancer.
Shimada C, Xu R, Al-Alem L, Stasenko M, Spriggs DR, Rueda BR. Shimada C, et al. Among authors: spriggs dr. Cancers (Basel). 2020 May 31;12(6):1421. doi: 10.3390/cancers12061421. Cancers (Basel). 2020. PMID: 32486344 Free PMC article. Review.
Progress in BRCA-Mutated Ovarian Cancer.
Spriggs DR, Longo DL. Spriggs DR, et al. N Engl J Med. 2018 Dec 27;379(26):2567-2568. doi: 10.1056/NEJMe1812644. N Engl J Med. 2018. PMID: 30586521 No abstract available.
PARP Inhibitors in Ovarian Cancer Treatment.
Spriggs DR, Longo DL. Spriggs DR, et al. N Engl J Med. 2016 Dec 1;375(22):2197-2198. doi: 10.1056/NEJMe1612843. N Engl J Med. 2016. PMID: 27959768 No abstract available.
Ovarian Cancer Treatment - Are We Getting Warmer?
Spriggs DR, Zivanovic O. Spriggs DR, et al. N Engl J Med. 2018 Jan 18;378(3):293-294. doi: 10.1056/NEJMe1714556. N Engl J Med. 2018. PMID: 29342385 No abstract available.
2-Year Outcomes After Transcatheter Versus Surgical Aortic Valve Replacement in Low-Risk Patients.
Forrest JK, Deeb GM, Yakubov SJ, Rovin JD, Mumtaz M, Gada H, O'Hair D, Bajwa T, Sorajja P, Heiser JC, Merhi W, Mangi A, Spriggs DJ, Kleiman NS, Chetcuti SJ, Teirstein PS, Zorn GL 3rd, Tadros P, Tchétché D, Resar JR, Walton A, Gleason TG, Ramlawi B, Iskander A, Caputo R, Oh JK, Huang J, Reardon MJ. Forrest JK, et al. Among authors: spriggs dj. J Am Coll Cardiol. 2022 Mar 8;79(9):882-896. doi: 10.1016/j.jacc.2021.11.062. J Am Coll Cardiol. 2022. PMID: 35241222 Free article. Clinical Trial.
New drugs for ovarian cancer.
Bell-McGuinn K, Konner J, Tew W, Spriggs DR. Bell-McGuinn K, et al. Among authors: spriggs dr. Ann Oncol. 2011 Dec;22 Suppl 8:viii77-viii82. doi: 10.1093/annonc/mdr531. Ann Oncol. 2011. PMID: 22180408 Free article. Review. No abstract available.
White heifer disease.
SPRIGGS DN. SPRIGGS DN. Vet Rec. 1946 Sep 14;58(37):405; passim. Vet Rec. 1946. PMID: 20274663 No abstract available.
Evaluation of Treatment With Talazoparib and Avelumab in Patients With Recurrent Mismatch Repair Proficient Endometrial Cancer.
Konstantinopoulos PA, Gockley AA, Xiong N, Krasner C, Horowitz N, Campos S, Wright AA, Liu JF, Shea M, Yeku O, Castro C, Polak M, Lee EK, Sawyer H, Bowes B, Moroney J, Cheng SC, Tayob N, Bouberhan S, Spriggs D, Penson RT, Fleming GF, Nucci MR, Matulonis UA. Konstantinopoulos PA, et al. Among authors: spriggs d. JAMA Oncol. 2022 Sep 1;8(9):1317-1322. doi: 10.1001/jamaoncol.2022.2181. JAMA Oncol. 2022. PMID: 35900726 Free PMC article. Clinical Trial.
Antibody-Peptide Epitope Conjugates for Personalized Cancer Therapy.
Zhang S, Yan C, Millar DG, Yang Q, Heather JM, Langenbucher A, Morton LT, Sepulveda S, Alpert E, Whelton LR, Zarrella DT, Guo M, Minogue E, Lawrence MS, Rueda BR, Spriggs DR, Lu W, Langenau DM, Cobbold M. Zhang S, et al. Among authors: spriggs dr. Cancer Res. 2022 Mar 1;82(5):773-784. doi: 10.1158/0008-5472.CAN-21-2200. Cancer Res. 2022. PMID: 34965933
New drugs in gynecologic cancer.
Daud A, Munster P, Munster P, Spriggs DR. Daud A, et al. Among authors: spriggs dr. Curr Treat Options Oncol. 2001 Apr;2(2):119-28. doi: 10.1007/s11864-001-0054-0. Curr Treat Options Oncol. 2001. PMID: 12057130 Review.
336 results